Quantum-Si Inc

Quantum-Si Inc (QSI) Stock Analysis

$0.780

-0.022 (-2.88%)At close

Loading chart…
High
0.822
Open
0.822
VWAP
0.79
Vol
2.42M
Mkt Cap
133.31M
Low
0.770
Amount
1.91M
EV/EBITDA, TTM
-0.36

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

AI analysis of Quantum-Si Inc (QSI)

hold

Quantum-Si Inc is currently not a strong buy due to ongoing financial losses and insider selling, despite a potential upside in the long term.

Valuation Metrics

The current forward P/E ratio for Quantum-Si Inc (QSI) is 0.00, compared to its 5-year average forward P/E of -3.49.

Forward P/E

Overvalued
5Y Average P/E
-3.49
Current P/E
0.00
Overvalued
-1.08
Undervalued
-5.90

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.63
Current EV/EBITDA
-0.36
Overvalued
1.00
Undervalued
-2.26

Forward P/S

Fair
5Y Average P/S
77.23
Current P/S
30.32
Overvalued
167.56
Undervalued
-13.11

Alphio AI Price Scenarios for QSI

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%QSI

$4.58

Scenario price

B

Base

Base · 50%QSI

$3.98

Scenario price

B

Bear

Bear · 25%QSI

$3.82

Scenario price

Events Timeline

2026-05-21 (ET)

08:50:00

Kodiak AI Borrow Rate Increases to 210.02%

2026-05-07 (ET)

16:50:00

Proteus Reports Q1 Revenue of $258K, Below Consensus

2026-04-28 (ET)

08:40:00

Quantum-Si Achieves Sequencing on Integrated Proteus Instruments

2026-04-14 (ET)

08:40:00

Quantum-Si Releases New Study on Human Cohesin Function in Yeast

2026-04-08 (ET)

09:20:00

Quantum-Si Completes Sequencing on Proteus Prototype System

News

QSI FAQ — answered by Alphio AI

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome. It operates in the Healthcare sector (MEASURING & CONTROLLING DEVICES, NEC industry).

Quantum-Si Inc is currently not a strong buy due to ongoing financial losses and insider selling, despite a potential upside in the long term.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started